Evidence map›Paper›PMID 32318774›Full record

SynthesisNeuroradiology2020

Promises of artificial intelligence in neuroradiology: a systematic technographic review.

Allard W Olthof, Peter M A van Ooijen, Mohammad H Rezazade Mehrizi

Abstract readSystematic Review
In one paragraph

Synthesis in Neuroradiology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Cerebral ischemia detection using deep learning techniques.Health information science and systems · 2025
    Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Allard W OlthofDepartment of Radiology, Treant Health Care Group, Dr. G.H. Amshoffweg 1, Hoogeveen, The Netherlands. a.olthof@treant.nl.
Peter M A van OoijenDepartment of Radiation Oncology, University of Groningen, University Medical Center Groningen, Hanzeplein 1, Groningen, The Netherlands.
Mohammad H Rezazade MehriziSchool of Business and Economics, Knowledge, Information and Innovation, KIN Center for Digital Innovation, Vrije Universiteit Amsterdam, De Boelelaan 1105, Amsterdam, The Netherlands.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeTo conduct a systematic review of the possibilities of artificial intelligence (AI) in neuroradiology by performing an objective, systematic assessment of available applications. To analyse the potential impacts of AI applications on the work of neuroradiologists.

methodsWe identified AI applications offered on the market during the period 2017-2019. We systematically collected and structured information in a relational database and coded for the characteristics of the applications, their functionalities for the radiology workflow and their potential impacts in terms of 'supporting', 'extending' and 'replacing' radiology tasks.

resultsWe identified 37 AI applications in the domain of neuroradiology from 27 vendors, together offering 111 functionalities. The majority of functionalities 'support' radiologists, especially for the detection and interpretation of image findings. The second-largest group of functionalities 'extends' the possibilities of radiologists by providing quantitative information about pathological findings. A small but noticeable portion of functionalities seek to 'replace' certain radiology tasks.

conclusionArtificial intelligence in neuroradiology is not only in the stage of development and testing but also available for clinical practice. The majority of functionalities support radiologists or extend their tasks. None of the applications can replace the entire radiology profession, but a few applications can do so for a limited set of tasks. Scientific validation of the AI products is more limited than the regulatory approval.

Indexed as

Artificial IntelligenceNeuroimagingHumansArtificial intelligence (AI)Machine learningNeurology/diagnostic imagingOrganizational innovationRadiologyTechnography

Identifiers

PMID32318774
PMCPMC7479016

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.